Skip to main content
. 2014 Nov 3;137(12):3142–3148. doi: 10.1093/brain/awu314

Table 1.

Clinical and pathological features of 27 essential tremor cases and 27 controls

Essential tremor cases Controls Significance
Age at death (years) 87.7 ± 7.4 85.0 ± 6.7 P = 0.16a
Female gender 14 (51.9) 21 (77.8) P = 0.046b
Age of tremor onset (years) 40.3 ± 26.3 Not applicable Not applicable
Duration of tremor (years) 47.5 ± 26.4 Not applicable Not applicable
Median post-mortem interval (h) 2 5.25 P = 0.001
Brain weight (g) 1212 ± 156 1176 ± 136 P = 0.36a
Braak Alzheimer’s disease scorec P = 0.16b
0 2 (7.4) 2 (18.2)
1 9 (33.3) 3 (27.3)
2 4 (14.8) 4 (36.4)
3 11 (40.7) 1 (9.1)
4 1 (3.7) 0 (0.0)
5 0 (0.0) 0 (0.0)
6 0 (0.0) 1 (9.1)
CERAD scorec P = 0.79b
0 11 (40.7) 4 (36.4)
A 10 (37.0) 5 (45.5)
B 4 (14.8) 2 (18.2)
C 2 (7.4) 0 (0.0)
Torpedo count (Luxol Fast blue and counterstained with haematoxylin and eosin) 17.7 ± 16.6 6.1 ± 7.5 P = 0.018a
Torpedo count (Bielschowsky) 25.8 ± 22.8 10.3 ± 10.3 P = 0.02a
Purkinje cell count 6.8 ± 1.8 8.5 ± 2.1 P = 0.025a
Purkinje cell linear density (cells/mm) 3.1 ± 0.8 3.9 ± 1.0 P = 0.025a

Values are mean ± standard deviation or number (percentage) unless specified otherwise.

aStudent t-test.

bChi-square test.

cData available on 11 rather than 27 control subjects.